Mon, 10 Aug 2020 03:02:10 GMT
China's CanSino to begin Phase III clinical trials
The Chinese vaccine maker CanSino Biologics will soon begin the Phase III clinical trials of the COVID-19 vaccine in Saudi Arabia, a spokesperson from the Saudi Health Ministry announced on Sunday.